Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232
Eric Larsen(New England Cancer Specialists), William L. Carroll(NYU Langone Health), Mignon L. Loh(Seattle Children's Hospital), Brent L. Wood(University of Southern California), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Catherine Cole(Maine Medical Center), Alisa L. Eicher(Maine Medical Center), Mark Sorenson(Maine Medical Center), Andrew A. Carroll(Maine Medical Center), Naomi Winick(The University of Texas Southwestern Medical Center), Cheryl L. Willman(Mayo Clinic), Leonard A. Mattano, Maureen Haugan(Maine Medical Center), Meenakshi Devidas(National Institutes of Health), Si Chen(Tianjin Hospital), Michael J. Borowitz(Johns Hopkins University), Wanda L. Salzer(Maine Medical Center), Nyla A. Heerema(The Ohio State University), Julie M. Gastier‐Foster(Nationwide Children's Hospital)
Cited by 380
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k